Skip to content

Changes in Regional and Global Cardiac Contractility After Stimulation in Scar Zone With the NOGA System

Changes in Regional and Global Cardiac Contractility After Stimulation in Scar Zone With the NOGA System

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04757168
Acronym
SCARPACE
Enrollment
10
Registered
2021-02-17
Start date
2022-02-23
Completion date
2024-01-26
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial Infarction

Keywords

stimulation in cardiac scar area

Brief summary

Despite a decrease in voltage amplitude in post-infarction scar areas, greater voltage amplitudes are sometimes observed at the time of local extrasystoles mechanically induced by catheters. However, no study has investigated whether these electrical changes are associated with mechanical changes in local contractility. However, the voltage is closely correlated to the local contractile function as evidenced by the use of the NOGA system.

Interventions

DEVICENOGA TM probe

Each subject will be his own witness since the linear local shortening (LLS) will be measured successively in all patients before, then after stimulation of the scar zone (comparison of LLS measured in sinus rhythm then during stimulation in the scar zone for each patient. Each subject being his own witness and the two recordings being made a few minutes apart, during the same procedure.

Sponsors

University Hospital, Toulouse
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

\- Patients who should undergo ventricular tachycardia (VT) ablation after a myocardial infarction according to current recommendations, namely: patients with ischemic heart disease (ICD) and with episodes of sustained ventricular tachycardia responsible for internal electric shocks by the implantable automatic defibrillator (ICD) (grade IB recommendation) OR * patients with an MIC and an ICD, presenting a first episode of sustained ventricular tachycardia (grade IIa, B recommendation) * Affiliated with a social protection scheme * Having signed an informed consent

Exclusion criteria

* Contraindication or non-indication for ventricular tachycardia ablation * Women who are pregnant or of childbearing age and without contraception, breastfeeding women * Patients without ischemic heart disease * Patients under guardianship, curatorship or legal protection.

Design outcomes

Primary

MeasureTime frameDescription
Evolution of LLS (linear local shortening) via the NOGATM system in percentage1monthStudy the change in percentage of LLS during stimulation in a post-infarction scar zone identified by voltage mapping of the left ventricle with the NOGA system, compared to LLS in the same zone measured in atrial stimulation

Secondary

MeasureTime frameDescription
Evolution of global systolic function: left ventricular ejection fraction1monthCompare the left ventricular ejection fraction (in percentage) during stimulation in a scar area compared to a normal rhythm
Evolution of the global systolic function: integral time velocity under aortic Translation results Evolution of the global systolic function: integral time velocity under aortic1monthCompare the integral time velocity under aortic (in centimeter) during stimulation in a scar area compared to a normal rhythm
Evolution of the global systolic function: strain longitudinal global1monthCompare the strain longitudinal global(in percentage) during stimulation in a scar area compared to a normal rhythm

Countries

France

Contacts

PRINCIPAL_INVESTIGATORAnne ROLLIN, MD

University Hospital, Toulouse

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 2, 2026